These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26108476)

  • 1. Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis.
    Liu Q; Li X; Li W; Du X; He JQ; Tao C; Feng Y
    Sci Rep; 2015 Jun; 5():11715. PubMed ID: 26108476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa.
    Tsao LH; Hsin CY; Liu HY; Chuang HC; Chen LY; Lee YJ
    J Microbiol Immunol Infect; 2018 Jun; 51(3):359-366. PubMed ID: 28988663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections.
    Lin KY; Lauderdale TL; Wang JT; Chang SC
    J Microbiol Immunol Infect; 2016 Feb; 49(1):52-9. PubMed ID: 24662016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies.
    Zhang Y; Chen XL; Huang AW; Liu SL; Liu WJ; Zhang N; Lu XZ
    Emerg Microbes Infect; 2016 Mar; 5(3):e27. PubMed ID: 27004762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
    Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
    J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections.
    Peña C; Suarez C; Gozalo M; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez F; Tubau F; Martínez-Martínez L; Oliver A;
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1265-72. PubMed ID: 22155832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome.
    Jeong SJ; Yoon SS; Bae IK; Jeong SH; Kim JM; Lee K
    Diagn Microbiol Infect Dis; 2014 Oct; 80(2):130-5. PubMed ID: 25112900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis.
    Chen Z; Xu Z; Wu H; Chen L; Gao S; Chen Y
    Am J Infect Control; 2019 Jun; 47(6):677-682. PubMed ID: 30554879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital.
    Zhang D; Cui K; Wang T; Shan Y; Dong H; Feng W; Ma C; Dong Y
    J Infect Dev Ctries; 2018 Aug; 12(8):642-648. PubMed ID: 31958327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of a hospital outbreak related to carbapenem-resistant Pseudomonas aeruginosa].
    Cekin Y; Karagöz A; Kızılateş F; Cekin AH; Oztoprak Çuvalcı N; Bülbüller N; Durmaz R
    Mikrobiyol Bul; 2013 Oct; 47(4):619-27. PubMed ID: 24237430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carbapenem resistance in Pseudomonas aeruginosa isolated from urine cultures: prevalence and risk factors].
    Álvarez-Otero J; Lamas-Ferreiro JL; González-González L; Rodríguez-Conde I; Fernández-Soneira MJ; Arca-Blanco A; Bermúdez-Sanjurjo JR; de la Fuente-Aguado J
    Rev Esp Quimioter; 2017 Jun; 30(3):183-194. PubMed ID: 28440605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenem-resistant
    Huang W; Wei X; Xu G; Zhang X; Wang X
    Front Public Health; 2023; 11():1088262. PubMed ID: 36844819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The impact of carbapenem-resistance
    Wei J; Zhu QL; Sun Z; Wang C
    Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):353-359. PubMed ID: 32370463
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study.
    Coppry M; Jeanne-Leroyer C; Noize P; Dumartin C; Boyer A; Bertrand X; Dubois V; Rogues AM
    J Antimicrob Chemother; 2019 Feb; 74(2):503-510. PubMed ID: 30376042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
    Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
    J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for hospital-acquired bacteremia due to carbapenem-resistant Pseudomonas aeruginosa in a Colombian hospital.
    Valderrama SL; González PF; Caro MA; Ardila N; Ariza B; Gil F; Álvarez C
    Biomedica; 2016 Feb; 36(0):69-77. PubMed ID: 27622627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.
    Kohlenberg A; Weitzel-Kage D; van der Linden P; Sohr D; Vögeler S; Kola A; Halle E; Rüden H; Weist K
    J Hosp Infect; 2010 Apr; 74(4):350-7. PubMed ID: 20170982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quick loss of carbapenem susceptibility in Pseudomonas aeruginosa at intensive care units.
    Zou Y; Lian J; Di Y; You H; Yao H; Liu J; Dong Y
    Int J Clin Pharm; 2018 Feb; 40(1):175-182. PubMed ID: 29134489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High mortality of bloodstream infection outbreak caused by carbapenem-resistant P. aeruginosa producing SPM-1 in a bone marrow transplant unit.
    Chaves L; Tomich LM; Salomão M; Leite GC; Ramos J; Martins RR; Rizek C; Neves P; Batista MV; Amigo U; Guimaraes T; Levin AS; Costa SF
    J Med Microbiol; 2017 Dec; 66(12):1722-1729. PubMed ID: 29095142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and mortality of carbapenem-resistant Pseudomonas aeruginosa bloodstream infection in haematology department: A 10-year retrospective study.
    Yuan F; Li M; Wang X; Fu Y
    J Glob Antimicrob Resist; 2024 Jun; 37():150-156. PubMed ID: 38615882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.